Why Families and Scientists Need Each Other

Why Families and Scientists Need Each Other In Neuroblastoma Research Every discovery in childhood cancer begins with a question — often one asked first by a parent.   In our July webinar, Dr. Giselle Sholler, Chair of the Beat Childhood Cancer Research Consortium, shared an insider’s view of what true collaboration between families and scientists […]

Global Collaboration: Why It Matters for Neuroblastoma Families

Global Collaboration: Why It Matters for Neuroblastoma Families September is Childhood Cancer Awareness Month — a reminder that every child’s fight deserves global urgency. This year, Shir for Life marked the month in two important ways: hosting our September 5th webinar with Dr. Lucas Moreno, President of SIOPEN, and later joining the international neuroblastoma community […]

What Surgery Can—and Can’t—Do in Neuroblastoma

Select What Surgery Can—and Can’t—Do in Neuroblastoma What Surgery Can—and Can’t—Do in Neuroblastoma A conversation with Dr. Michael LaQuaglia, Chief of Pediatric Surgery at Memorial Sloan Kettering When a child is diagnosed with neuroblastoma, surgery is often one of the first things families ask about. What kind of surgery will be needed? Can the tumor […]

Risk vs. Stage: What’s the Difference in Neuroblastoma?

Risk vs. Stage: What’s the Difference in Neuroblastoma? Insights from Dr. Susan Cohn | February, 2025 Neuroblastoma Series Webinar For families navigating a neuroblastoma diagnosis, one of the most confusing aspects is understanding the difference between stage and risk classification. Many assume that all Stage 4 neuroblastoma cases are the same, but the reality is much […]

What to ask after a neuroblastoma Relapse

What to ask after a neuroblastoma Relapse Insights from Dr. Brian H. Kushner | April, 2025 Neuroblastoma Series Webinar   When a child’s neuroblastoma relapses, it can feel like the ground disappears beneath you. But it’s not the end of the road.   Dr. Brian H. Kushner, a leading pediatric oncologist at Memorial Sloan Kettering […]

A Milestone for Research: Shir for Life Funds Breakthrough Immunotherapy Research at CHOP

A Milestone for Research: Shir for Life Funds Breakthrough Immunotherapy Research at CHOP March, 2025 – Shir for Life completed its second major payment to support an innovative research project at Children’s Hospital of Philadelphia (CHOP), bringing our total funding to $180,000. This contribution is helping drive the development of a first-in-class targeted immunotherapy for […]